Cargando…
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence
BACKGROUND: The significance of the expression of aldehyde dehydrogenase 1 (ALDH1), a cancer stem cell marker, for predicting the recurrence of estrogen receptor (ER)-positive/human epidermal growth factor receptor type 2 (HER2)-negative breast cancer is still poorly understood. The value of ALDH1 i...
Autores principales: | Miyoshi, Yuichiro, Shien, Tadahiko, Ogiya, Akiko, Ishida, Naoko, Yamazaki, Kieko, Horii, Rie, Horimoto, Yoshiya, Masuda, Norikazu, Yasojima, Hiroyuki, Inao, Touko, Osako, Tomofumi, Takahashi, Masato, Tomioka, Nobumoto, Endo, Yumi, Hosoda, Mitsuchika, Doihara, Hiroyoshi, Miyoshi, Shinichiro, Yamashita, Hiroko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930566/ https://www.ncbi.nlm.nih.gov/pubmed/27368476 http://dx.doi.org/10.1186/s13058-016-0731-3 |
Ejemplares similares
-
Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer
por: Miyoshi, Yuichiro, et al.
Publicado: (2019) -
The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells
por: Ikeda, Hirokuni, et al.
Publicado: (2010) -
A Case of Carcinoma Showing Thymus-Like Differentiation with a Rapidly Lethal Course
por: Nogami, Tomohiro, et al.
Publicado: (2014) -
Fertility preservation in breast cancer patients
por: Shien, Tadahiko, et al.
Publicado: (2013) -
Effect of local surgery on outcomes of stage IV breast cancer
por: Tsukioki, Takahiro, et al.
Publicado: (2020)